Skip to main content
Top
Published in: Journal of Translational Medicine 1/2009

Open Access 01-12-2009 | Research

Is there a relationship between factor V Leiden and type 2 diabetes?

Authors: Corrado Lodigiani, Paola Ferrazzi, Pierpaolo Di Micco, Luca Librè, Stefano Genovese, Ilaria Quaglia, Lidia Luciana Rota

Published in: Journal of Translational Medicine | Issue 1/2009

Login to get access

Abstract

Background

Diabetes is well known risk factor for thrombotic events. The association between diabetes and venous thromboembolism is still matter of debate. However, during diabetes an acquired thrombophilia is present and is due to the non-enzymatic glycosilation of clotting inhibitors as antithrombin thus leading to hypercoagulable state. A possibile relationship between the presence of FVL gene variant in type 1 or type 2 diabetes has been hypothysed by several reports in the Literature with non-univocal findings.

Patients and methods

Retrospectively we analysed nearly 7000 patients referred to our Thrombosis Center for venous thromboembolism (VTE) then we selected 115 patients underwent to the screening for inherited thrombophilia. All selected patients were divided in 2 groups: the first group (group A) included 64 patients with previous VTE and carriers of factor V Leiden, while the second group (group B) included 51 patients with previous VTE and evetually carriers of thrombophilic defects other than factor V Leiden. Patients of group B acted as control group. 75 g oral glucose tolerance Test (OGTT) recommended by WHO was perfomed to all subjects in the study in order to screen subjects with glucose reduced tolerance or subjects with inducible diabetes. Statistical analysis was performed with STATA 6 http://​www.​stata.​com with Student t test for unpaired data, with χ2 test or with Fisher exact test where appropriated; differences were considered to be significant if p < 0.05.

Results

We did not find sifferences between glycaemia at baseline and after OGTT between patients with VTE carriers of FVL compared to non-carriers of FVL. We found a relevant increase in the prevalence of IGT and diabetes between patients with VTE carriers of FVL compared to non-carriers of FVL although this increase did not raise statistical significance.

Discussion

our data pointed out an interesting aspect of the linking between FVL gene variant, diabetes and atherothrombosis and other vascular complications, although data on larger population are needed; this aspect may be another relevant topic of research based because also a link between the pathogenesis of venous thrombosis and atherothrombosis has been recently reported in the Literature.
Literature
1.
go back to reference Fumelli P, Romagnoli F, Carlino G, Fumelli C, Boemi M: Diabetes mellitus and chronic heart failure. Arch Gerontol Geriatr. 1996, 23: 277-281. 10.1016/S0167-4943(96)00736-4.CrossRefPubMed Fumelli P, Romagnoli F, Carlino G, Fumelli C, Boemi M: Diabetes mellitus and chronic heart failure. Arch Gerontol Geriatr. 1996, 23: 277-281. 10.1016/S0167-4943(96)00736-4.CrossRefPubMed
2.
go back to reference Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham study. JAMA. 1979, 241: 2035-2038. 10.1001/jama.241.19.2035.CrossRefPubMed Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham study. JAMA. 1979, 241: 2035-2038. 10.1001/jama.241.19.2035.CrossRefPubMed
3.
go back to reference Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC: Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes. 1992, 41 (2): 202-208. 10.2337/diabetes.41.2.202.CrossRefPubMed Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC: Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes. 1992, 41 (2): 202-208. 10.2337/diabetes.41.2.202.CrossRefPubMed
4.
go back to reference Dorman JS, Laporte RE, Kuller LH, Cruickshanks KJ, Orchard TJ, Wagener DK, Becker DJ, Cavender DE, Drash AL: The Pittsburgh Study of insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes. 1984, 33: 271-277. 10.2337/diabetes.33.3.271.CrossRefPubMed Dorman JS, Laporte RE, Kuller LH, Cruickshanks KJ, Orchard TJ, Wagener DK, Becker DJ, Cavender DE, Drash AL: The Pittsburgh Study of insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes. 1984, 33: 271-277. 10.2337/diabetes.33.3.271.CrossRefPubMed
5.
go back to reference Targher G, Bertolini L, Padovani R, Poli F, Scala L, Tessari R, Zenari L, Falezza G: Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease. Diabet Med. 2006, 23 (4): 403-409. 10.1111/j.1464-5491.2006.01817.x.CrossRefPubMed Targher G, Bertolini L, Padovani R, Poli F, Scala L, Tessari R, Zenari L, Falezza G: Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease. Diabet Med. 2006, 23 (4): 403-409. 10.1111/j.1464-5491.2006.01817.x.CrossRefPubMed
6.
go back to reference Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH: A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997, 277 (8): 642-645. 10.1001/jama.277.8.642.CrossRefPubMed Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH: A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997, 277 (8): 642-645. 10.1001/jama.277.8.642.CrossRefPubMed
7.
go back to reference Movahed MR, Hashemzadeh M, Jamal MM: The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus. Chest. 2005, 128 (5): 3568-3571. 10.1378/chest.128.5.3568.PubMed Movahed MR, Hashemzadeh M, Jamal MM: The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus. Chest. 2005, 128 (5): 3568-3571. 10.1378/chest.128.5.3568.PubMed
8.
go back to reference Franchini M, Mannucci PM: Venous and arterial thrombosis: different sides of the same coin?. Eur J Intern Med. 2008, 19 (7): 476-481. 10.1016/j.ejim.2007.10.019.CrossRefPubMed Franchini M, Mannucci PM: Venous and arterial thrombosis: different sides of the same coin?. Eur J Intern Med. 2008, 19 (7): 476-481. 10.1016/j.ejim.2007.10.019.CrossRefPubMed
9.
go back to reference Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA. 2000, 283 (2): 221-228. 10.1001/jama.283.2.221.CrossRefPubMed Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA. 2000, 283 (2): 221-228. 10.1001/jama.283.2.221.CrossRefPubMed
10.
go back to reference Ceriello A, Giugliano D, Dello Russo P, Tirelli A, Passariello N, Sgambato S: Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation. Diabetes Care. 1986, 9: 32-35. 10.2337/diacare.9.1.32.CrossRefPubMed Ceriello A, Giugliano D, Dello Russo P, Tirelli A, Passariello N, Sgambato S: Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation. Diabetes Care. 1986, 9: 32-35. 10.2337/diacare.9.1.32.CrossRefPubMed
11.
go back to reference Martinelli I: Risk factors in venous thromboembolism. Thromb Haemost. 2001, 86: 395-403.PubMed Martinelli I: Risk factors in venous thromboembolism. Thromb Haemost. 2001, 86: 395-403.PubMed
12.
go back to reference Haapaniemi E, Helenius J, Jakovljeviæ D, Soinne L, Syrjälä M, Kaste M, Lassila R, Tatlisumak T: Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease. Thromb Haemost. 2009, 101 (1): 145-150.PubMed Haapaniemi E, Helenius J, Jakovljeviæ D, Soinne L, Syrjälä M, Kaste M, Lassila R, Tatlisumak T: Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease. Thromb Haemost. 2009, 101 (1): 145-150.PubMed
13.
go back to reference Simioni P, de Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A: Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke. 1995, 26 (5): 885-890.CrossRefPubMed Simioni P, de Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A: Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke. 1995, 26 (5): 885-890.CrossRefPubMed
14.
go back to reference Demirer AN, Alikasifoglu M, Tuncbilek E, Karakus S, Erbas T: Factor V Leiden mutation and type 1 diabetes mellitus. Blood Coagul Fibrinolysis. 2008, 19 (1): 70-74. 10.1097/MBC.0b013e3282f38c5f.CrossRefPubMed Demirer AN, Alikasifoglu M, Tuncbilek E, Karakus S, Erbas T: Factor V Leiden mutation and type 1 diabetes mellitus. Blood Coagul Fibrinolysis. 2008, 19 (1): 70-74. 10.1097/MBC.0b013e3282f38c5f.CrossRefPubMed
15.
go back to reference Hart LM, Stolk RP, Dekker JM, Nijpels G, Grobbee DE, Heine RJ, Maassen JA: Prevalence of variants in candidate genes for type 2 diabetes mellitus in the Netherlands: the Rotterdam study and the Hoorn study. J Clin Endocrinol Metab. 1999, 84 (3): 1002-1006. 10.1210/jc.84.3.1002.PubMed Hart LM, Stolk RP, Dekker JM, Nijpels G, Grobbee DE, Heine RJ, Maassen JA: Prevalence of variants in candidate genes for type 2 diabetes mellitus in the Netherlands: the Rotterdam study and the Hoorn study. J Clin Endocrinol Metab. 1999, 84 (3): 1002-1006. 10.1210/jc.84.3.1002.PubMed
16.
go back to reference Krekora K, De Lucia D, Capani F, Donati MB, Iacoviello L: Association of coagulation factor VArg506Gln mutation with non-insulin-dependent diabetes mellitus. Lancet. 1996, 348 (9042): 1666-1667. 10.1016/S0140-6736(05)65740-6.CrossRefPubMed Krekora K, De Lucia D, Capani F, Donati MB, Iacoviello L: Association of coagulation factor VArg506Gln mutation with non-insulin-dependent diabetes mellitus. Lancet. 1996, 348 (9042): 1666-1667. 10.1016/S0140-6736(05)65740-6.CrossRefPubMed
Metadata
Title
Is there a relationship between factor V Leiden and type 2 diabetes?
Authors
Corrado Lodigiani
Paola Ferrazzi
Pierpaolo Di Micco
Luca Librè
Stefano Genovese
Ilaria Quaglia
Lidia Luciana Rota
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2009
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-7-52

Other articles of this Issue 1/2009

Journal of Translational Medicine 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.